Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 119 articles:
HTML format
Text format



Single Articles


    November 2018
  1. LIU H, Peng J, Zhao M, Ma P, et al
    Downregulation of DLL4 predicts poor survival in nonsmall cell lung cancer patients due to promotion of lymph node metastasis.
    Oncol Rep. 2018;40:2988-2996.
    PubMed     Text format     Abstract available


  2. LI B, Ding CM, Li YX, Peng JC, et al
    MicroRNA145 inhibits migration and induces apoptosis in human nonsmall cell lung cancer cells through regulation of the EGFR/PI3K/AKT signaling pathway.
    Oncol Rep. 2018;40:2944-2954.
    PubMed     Text format     Abstract available


  3. XIANG R, Cui Y, Wang Y, Xie T, et al
    Circadian clock gene Per2 downregulation in nonsmall cell lung cancer is associated with tumour progression and metastasis.
    Oncol Rep. 2018;40:3040-3048.
    PubMed     Text format     Abstract available


    October 2018
  4. GAO J, Qiu X, Xi G, Liu H, et al
    Downregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR/Akt signaling and predicts a good prognosis in nonsmall cell lung cancer.
    Oncol Rep. 2018;40:1971-1984.
    PubMed     Text format     Abstract available


  5. LI TT, He RQ, Ma J, Li ZY, et al
    Long noncoding RNAs in small cell lung cancer: A potential opening to combat the disease (Review).
    Oncol Rep. 2018;40:1831-1842.
    PubMed     Text format     Abstract available


    August 2018
  6. LIU KT, Yeh IJ, Chou SK, Yen MC, et al
    Regulatory mechanism of fatty acidCoA metabolic enzymes under endoplasmic reticulum stress in lung cancer.
    Oncol Rep. 2018 Aug 21. doi: 10.3892/or.2018.6664.
    PubMed     Text format     Abstract available


  7. HU P, Wong PT, Zhou Q, Sheng L, et al
    Clinical relevance of the multidrug resistanceassociated protein 1 gene in nonsmall cell lung cancer: A systematic review and metaanalysis.
    Oncol Rep. 2018 Aug 17. doi: 10.3892/or.2018.6652.
    PubMed     Text format     Abstract available


  8. ZHANG J, Wen G, Sun L, Yuan W, et al
    Cryptotanshinone inhibits cellular proliferation of human lung cancer cells through downregulation ofIGF-1R/PI3K/Akt signaling pathway.
    Oncol Rep. 2018 Aug 10. doi: 10.3892/or.2018.6638.
    PubMed     Text format     Abstract available


    July 2018
  9. ZHONG L, Sun S, Yao S, Han X, et al
    Histone deacetylase 5 promotes the proliferation and invasion of lung cancer cells.
    Oncol Rep. 2018 Jul 24. doi: 10.3892/or.2018.6591.
    PubMed     Text format     Abstract available


  10. HUANG C, Yang M, Deng J, Li P, et al
    Upregulation and activation of p53 by erastininduced reactive oxygen species contribute to cytotoxic and cytostatic effects in A549 lung cancer cells.
    Oncol Rep. 2018 Jul 20. doi: 10.3892/or.2018.6585.
    PubMed     Text format     Abstract available


  11. WANG Y, He J, Jiang H, Zhang Q, et al
    Nicotine enhances storeoperated calcium entry by upregulating HIF1alpha and SOCC components in nonsmall cell lung cancer cells.
    Oncol Rep. 2018 Jul 17. doi: 10.3892/or.2018.6580.
    PubMed     Text format     Abstract available


  12. GONG Q, Cao X, Cao J, Yang X, et al
    Casticin suppresses the carcinogenesis of small cell lung cancer H446 cells through activation of AMPK/FoxO3a signaling.
    Oncol Rep. 2018 Jul 5. doi: 10.3892/or.2018.6547.
    PubMed     Text format     Abstract available


    June 2018
  13. PARK WH
    Hydrogen peroxide inhibits the growth of lung cancer cells via the induction of cell death and G1phase arrest.
    Oncol Rep. 2018 Jun 28. doi: 10.3892/or.2018.6535.
    PubMed     Text format     Abstract available


  14. GU Y, Zhang M
    Upregulation of the Kank1 gene inhibits human lung cancer progression in vitro and in vivo.
    Oncol Rep. 2018 Jun 26. doi: 10.3892/or.2018.6526.
    PubMed     Text format     Abstract available


  15. CUI E, Guo H, Shen M, Yu H, et al
    Adiponectin inhibits migration and invasion by reversing epithelialmesenchymal transition in nonsmall cell lung carcinoma.
    Oncol Rep. 2018 Jun 25. doi: 10.3892/or.2018.6523.
    PubMed     Text format     Abstract available


  16. ZHANG L, Qi Y, Xing K, Qian S, et al
    A novel strategy of EGFRTKI combined chemotherapy in the treatment of human lung cancer with EGFRsensitive mutation.
    Oncol Rep. 2018 Jun 18. doi: 10.3892/or.2018.6499.
    PubMed     Text format     Abstract available


  17. JIANG K, Shen M, Chen Y, Xu W, et al
    miR150 promotes the proliferation and migration of nonsmall cell lung cancer cells by regulating the SIRT2/JMJD2A signaling pathway.
    Oncol Rep. 2018 Jun 12. doi: 10.3892/or.2018.6487.
    PubMed     Text format     Abstract available


  18. JIN D, Wu Y, Shao C, Gao Y, et al
    Norcantharidin reverses cisplatin resistance and inhibits the epithelial mesenchymal transition of human nonsmall lung cancer cells by regulating the YAP pathway.
    Oncol Rep. 2018 Jun 12. doi: 10.3892/or.2018.6486.
    PubMed     Text format     Abstract available


  19. LI F, Zhu T, Yue Y, Zhu X, et al
    Preliminary mechanisms of regulating PDL1 expression in nonsmall cell lung cancer during the EMT process.
    Oncol Rep. 2018 Jun 5. doi: 10.3892/or.2018.6474.
    PubMed     Text format     Abstract available


  20. JI Y, Jiang J, Huang L, Feng W, et al
    Spermassociated antigen 4 (SPAG4) as a new cancer marker interacts with Nesprin3 to regulate cell migration in lung carcinoma.
    Oncol Rep. 2018 Jun 4. doi: 10.3892/or.2018.6473.
    PubMed     Text format     Abstract available


  21. ZHANG Y, He S, Mei R, Kang Y, et al
    miR29a suppresses IL13induced cell invasion by inhibiting YY1 in the AKT pathway in lung adenocarcinoma A549 cells.
    Oncol Rep. 2018;39:2613-2623.
    PubMed     Text format     Abstract available


  22. YANG J, Li L, Xu C, Yang D, et al
    CT1042, a novel anticancer agent, exhibits effects by activating p53 and inhibiting survivin.
    Oncol Rep. 2018;39:2759-2768.
    PubMed     Text format     Abstract available


    May 2018
  23. SATAR NA, Fakiruddin KS, Lim MN, Mok PL, et al
    Novel triplepositive markers identified in human nonsmall cell lung cancer cell line with chemotherapy-resistant and putative cancer stem cell characteristics.
    Oncol Rep. 2018 May 24. doi: 10.3892/or.2018.6461.
    PubMed     Text format     Abstract available


  24. XU G, Du J, Wang F, Zhang F, et al
    RAD52 motifcontaining protein 1 promotes nonsmall cell lung cancer cell proliferation and survival via cell cycle regulation.
    Oncol Rep. 2018 May 23. doi: 10.3892/or.2018.6459.
    PubMed     Text format     Abstract available


  25. CHEN T, Li B, Xu Y, Meng S, et al
    Luteolin reduces cancerinduced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model.
    Oncol Rep. 2018 May 21. doi: 10.3892/or.2018.6453.
    PubMed     Text format     Abstract available


  26. WAN J, Ling X, Peng B, Ding G, et al
    miR-142-5p regulates CD4+ T cells in human non-small cell lung cancer through PD-L1 expression via the PTEN pathway.
    Oncol Rep. 2018 May 16. doi: 10.3892/or.2018.6439.
    PubMed     Text format     Abstract available


  27. LIN C, Qin Y, Zhang H, Gao MY, et al
    EGF upregulates RFPL3 and hTERT via the MEK signaling pathway in nonsmall cell lung cancer cells.
    Oncol Rep. 2018 May 8. doi: 10.3892/or.2018.6417.
    PubMed     Text format     Abstract available


  28. WANG M, Liu Y, Qian X, Wei N, et al
    Downregulation of occludin affects the proliferation, apoptosis and metastatic properties of human lung carcinoma.
    Oncol Rep. 2018 May 2. doi: 10.3892/or.2018.6408.
    PubMed     Text format     Abstract available


  29. PAN Y, Wang H, Ma D, Ji Z, et al
    miR24 may be a negative regulator of menin in lung cancer.
    Oncol Rep. 2018;39:2342-2350.
    PubMed     Text format     Abstract available


  30. XU S, Yang F, Liu R, Li X, et al
    Serum microRNA-139-5p is downregulated in lung cancer patients with lytic bone metastasis.
    Oncol Rep. 2018;39:2376-2384.
    PubMed     Text format     Abstract available


  31. LI Y, Wei Y, Yuan W, Huang Q, et al
    DNA damage induced by human CD40 ligand mutant promotes senescence and induces demethylation of GATA4 in lung cancer.
    Oncol Rep. 2018;39:2071-2080.
    PubMed     Text format     Abstract available


    April 2018
  32. DING J, Jia X, Zuo B, He J, et al
    A novel monoclonal antibody targeting a novel epitope of VEcadherin inhibits vasculogenic mimicry of lung cancer cells.
    Oncol Rep. 2018 Apr 16. doi: 10.3892/or.2018.6374.
    PubMed     Text format     Abstract available


  33. LIU L, Han C, Yu H, Zhu W, et al
    Chloroquine inhibits cell growth in human A549 lung cancer cells by blocking autophagy and inducing mitochondrialmediated apoptosis.
    Oncol Rep. 2018 Apr 12. doi: 10.3892/or.2018.6363.
    PubMed     Text format     Abstract available


  34. OH YJ, Park SY, Seo YH
    The targeted inhibition of Hsp90 by a synthetic small molecule, DPide offers an effective treatment strategy against TNBCs.
    Oncol Rep. 2018;39:1775-1782.
    PubMed     Text format     Abstract available


  35. ZHOU J, Hu Q, Zhang X, Zheng J, et al
    Sensitivity to chemotherapeutics of NSCLC cells with acquired resistance to EGFR-TKIs is mediated by T790M mutation or epithelial-mesenchymal transition.
    Oncol Rep. 2018;39:1783-1792.
    PubMed     Text format     Abstract available


    March 2018
  36. MA Y, Wu X, Xiu Z, Liu X, et al
    Cytochalasin H isolated from mangrovederived endophytic fungus induces apoptosis and inhibits migration in lung cancer cells.
    Oncol Rep. 2018 Mar 30. doi: 10.3892/or.2018.6347.
    PubMed     Text format     Abstract available


  37. PARK BR, Lee SA, Moon SM, Kim CS, et al
    Anthricininduced caspasedependent apoptosis through IGF1R/PI3K/AKT pathway inhibition in A549 human nonsmall lung cancer cells.
    Oncol Rep. 2018 Mar 27. doi: 10.3892/or.2018.6333.
    PubMed     Text format     Abstract available


  38. LIU M, Liu H, Chen J
    Mechanisms of the CDK4/6 inhibitor palbociclib (PD 0332991) and its future application in cancer treatment (Review).
    Oncol Rep. 2018;39:901-911.
    PubMed     Text format     Abstract available


  39. HE X, Zhang C, Shi C, Lu Q, et al
    Meta-analysis of mRNA expression profiles to identify differentially expressed genes in lung adenocarcinoma tissue from smokers and non-smokers.
    Oncol Rep. 2018;39:929-938.
    PubMed     Text format     Abstract available


  40. ISHIWATA T, Iwasawa S, Ebata T, Fan M, et al
    Inhibition of Gli leads to antitumor growth and enhancement of cisplatin-induced cytotoxicity in large cell neuroendocrine carcinoma of the lung.
    Oncol Rep. 2018;39:1148-1154.
    PubMed     Text format     Abstract available


    February 2018
  41. WANG Q, Chen Y, Feng H, Zhang B, et al
    Prognostic and predictive value of HURP in nonsmall cell lung cancer.
    Oncol Rep. 2018 Feb 26. doi: 10.3892/or.2018.6280.
    PubMed     Text format     Abstract available


  42. BAEK JH, Yim JH, Song JY, Um HD, et al
    Knockdown of end-binding protein 1 induces apoptosis in radioresistant A549 lung cancer cells via p38 kinase-dependent COX-2 upregulation.
    Oncol Rep. 2018 Feb 22. doi: 10.3892/or.2018.6278.
    PubMed     Text format     Abstract available


  43. TIAN H, Yin L, Ding K, Xia YY, et al
    Raf1 is a prognostic factor for progression in patients with nonsmall cell lung cancer after radiotherapy.
    Oncol Rep. 2018 Feb 22. doi: 10.3892/or.2018.6277.
    PubMed     Text format     Abstract available


  44. LIU J, Xing Y, Rong L
    miR-181 regulates cisplatin-resistant non-small cell lung cancer via downregulation of autophagy through the PTEN/PI3K/AKT pathway.
    Oncol Rep. 2018 Feb 13. doi: 10.3892/or.2018.6268.
    PubMed     Text format     Abstract available


  45. KEERATICHAMROEN S, Lirdprapamongkol K, Svasti J
    Mechanism of ECM-induced dormancy and chemoresistance in A549 human lung carcinoma cells.
    Oncol Rep. 2018 Feb 12. doi: 10.3892/or.2018.6258.
    PubMed     Text format     Abstract available


  46. CHANG WA, Yen MC, Hung JY, Yang CJ, et al
    Investigation of the role of tumor necrosis factor-like weak inducer of apoptosis in non-small cell lung cancer.
    Oncol Rep. 2018;39:573-581.
    PubMed     Text format     Abstract available


  47. HUANG F, Chen J, Wang Z, Lan R, et al
    delta-Catenin promotes tumorigenesis and metastasis of lung adenocarcinoma.
    Oncol Rep. 2018;39:809-817.
    PubMed     Text format     Abstract available


    January 2018
  48. HU Y, Li X, Lin L, Liang S, et al
    Puerarin inhibits non-small cell lung cancer cell growth via the induction of apoptosis.
    Oncol Rep. 2018 Jan 26. doi: 10.3892/or.2018.6234.
    PubMed     Text format     Abstract available


  49. SEO YS, Kang OH, Kong R, Zhou T, et al
    Polygalacin D induces apoptosis and cell cycle arrest via the PI3K/Akt pathway in non-small cell lung cancer.
    Oncol Rep. 2018 Jan 23. doi: 10.3892/or.2018.6230.
    PubMed     Text format     Abstract available


  50. LI B, Ding CM, Li YX, Peng JC, et al
    Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR.
    Oncol Rep. 2018 Jan 15. doi: 10.3892/or.2018.6215.
    PubMed     Text format     Abstract available


  51. KANAJI N, Kamitori K, Hossain A, Noguchi C, et al
    Additive antitumour effect of Dallose in combination with cisplatin in non-small cell lung cancer cells.
    Oncol Rep. 2018 Jan 4. doi: 10.3892/or.2018.6192.
    PubMed     Text format     Abstract available


  52. LIU F, Gao S, Yang Y, Zhao X, et al
    Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K/Akt/mTOR pathway.
    Oncol Rep. 2018 Jan 4. doi: 10.3892/or.2018.6188.
    PubMed     Text format     Abstract available


  53. FU S, Liu C, Huang Q, Fan S, et al
    Estrogen receptor beta1 activation accelerates resistance to epidermal growth factor receptor-tyrosine kinase inhibitors in non-small cell lung cancer.
    Oncol Rep. 2018 Jan 4. doi: 10.3892/or.2018.6186.
    PubMed     Text format     Abstract available


  54. TANG Z, Shen Q, Xie H, Zhou Z, et al
    Serum and glucocorticoid-regulated kinase 1 (SGK1) is a predictor of poor prognosis in non-small cell lung cancer, and its dynamic pattern following treatment with SGK1 inhibitor and gamma-ray irradiation was elucidated.
    Oncol Rep. 2018 Jan 3. doi: 10.3892/or.2018.6181.
    PubMed     Text format     Abstract available


  55. OLBROMSKI M, Rzechonek A, Grzegrzolka J, Glatzel-Plucinska N, et al
    Influence of miR-7a and miR-24-3p on the SOX18 transcript in lung adenocarcinoma.
    Oncol Rep. 2018;39:201-208.
    PubMed     Text format     Abstract available


    December 2017
  56. ZHAO L, Liu L, Dong Z, Xiong J, et al
    miR-149 suppresses human non-small cell lung cancer growth and metastasis by inhibiting the FOXM1/cyclin D1/MMP2 axis.
    Oncol Rep. 2017;38:3522-3530.
    PubMed     Text format     Abstract available


    November 2017
  57. TANG C, Luo H, Luo D, Yang H, et al
    Src homology phosphotyrosyl phosphatase 2 mediates cisplatin-related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells.
    Oncol Rep. 2017 Nov 24. doi: 10.3892/or.2017.6109.
    PubMed     Text format     Abstract available


  58. LI Y, Hu T, Chen T, Yang T, et al
    Combination treatment of FTY720 and cisplatin exhibits enhanced antitumour effects on cisplatin-resistant non-small lung cancer cells.
    Oncol Rep. 2017 Nov 24. doi: 10.3892/or.2017.6111.
    PubMed     Text format     Abstract available


  59. PARK WH
    MAPK inhibitors, particularly the JNK inhibitor, increase cell death effects in H2O2-treated lung cancer cells via increased superoxide anion and glutathione depletion.
    Oncol Rep. 2017 Nov 24. doi: 10.3892/or.2017.6107.
    PubMed     Text format     Abstract available


  60. ZHANG C, Xiao X, Chen M, Aldharee H, et al
    Liver kinase B1 restoration promotes exosome secretion and motility of lung cancer cells.
    Oncol Rep. 2017 Nov 9. doi: 10.3892/or.2017.6085.
    PubMed     Text format     Abstract available


  61. JIMENEZ-HERNANDEZ LE, Vazquez-Santillan K, Castro-Oropeza R, Martinez-Ruiz G, et al
    NRP1-positive lung cancer cells possess tumor-initiating properties.
    Oncol Rep. 2017 Nov 9. doi: 10.3892/or.2017.6089.
    PubMed     Text format     Abstract available


  62. YANG L, Zha TQ, He X, Chen L, et al
    Placenta-specific protein 1 promotes cell proliferation and invasion in non-small cell lung cancer.
    Oncol Rep. 2017 Nov 9. doi: 10.3892/or.2017.6086.
    PubMed     Text format     Abstract available


  63. WANG H, Zhang Y, Wu Q, Wang YB, et al
    miR-16 mimics inhibit TGF-beta1-induced epithelial-to-mesenchymal transition via activation of autophagy in non-small cell lung carcinoma cells.
    Oncol Rep. 2017 Nov 9. doi: 10.3892/or.2017.6088.
    PubMed     Text format     Abstract available


    October 2017
  64. NI X, Cao X, Wu Y, Wu J, et al
    FSTL1 suppresses tumor cell proliferation, invasion and survival in non-small cell lung cancer.
    Oncol Rep. 2017 Oct 31. doi: 10.3892/or.2017.6061.
    PubMed     Text format     Abstract available


  65. XU Z, Xu J, Lu H, Lin B, et al
    LARP1 is regulated by the XIST/miR-374a axis and functions as an oncogene in non-small cell lung carcinoma.
    Oncol Rep. 2017 Oct 17. doi: 10.3892/or.2017.6040.
    PubMed     Text format     Abstract available


  66. ZHANG C, Yu P, Zhu L, Zhao Q, et al
    Blockade of alpha7 nicotinic acetylcholine receptors inhibit nicotine-induced tumor growth and vimentin expression in non-small cell lung cancer through MEK/ERK signaling way.
    Oncol Rep. 2017 Oct 2. doi: 10.3892/or.2017.6014.
    PubMed     Text format     Abstract available


    September 2017
  67. QIU X, Guan X, Liu W, Zhang Y, et al
    DAL-1 attenuates epithelial to mesenchymal transition and metastasis by suppressing HSPA5 expression in non-small cell lung cancer.
    Oncol Rep. 2017 Sep 26. doi: 10.3892/or.2017.6000.
    PubMed     Text format     Abstract available


  68. XU M, Tang X, Guo J, Sun W, et al
    Reversal effect of adenovirus-mediated human interleukin 24 transfection on the cisplatin resistance of A549/DDP lung cancer cells.
    Oncol Rep. 2017 Sep 26. doi: 10.3892/or.2017.6002.
    PubMed     Text format     Abstract available


  69. WANG RH, Cao HM, Tian ZJ, Jin B, et al
    [Retracted] Efficacy of dual-functional liposomes containing paclitaxel for treatment of lung cancer.
    Oncol Rep. 2017 Sep 26. doi: 10.3892/or.2017.6006.
    PubMed     Text format     Abstract available


  70. WEI Y, Li D, Wang D, Qiu T, et al
    Evaluation of microRNA-203 in bone metastasis of patients with non-small cell lung cancer through TGF-beta/SMAD2 expression.
    Oncol Rep. 2017 Sep 21. doi: 10.3892/or.2017.5987.
    PubMed     Text format     Abstract available


  71. TIAN C, Li J, Ren L, Peng R, et al
    MicroRNA-381 serves as a prognostic factor and inhibits migration and invasion in non-small cell lung cancer by targeting LRH-1.
    Oncol Rep. 2017 Sep 14. doi: 10.3892/or.2017.5956.
    PubMed     Text format     Abstract available


  72. LI Y, Wang C, Li D, Deng P, et al
    1H-NMR-based metabolic profiling of a colorectal cancer CT-26 lung metastasis model in mice.
    Oncol Rep. 2017 Sep 13. doi: 10.3892/or.2017.5954.
    PubMed     Text format     Abstract available


  73. HAN Z, Zhou X, Li S, Qin Y, et al
    Inhibition of miR-23a increases the sensitivity of lung cancer stem cells to erlotinib through PTEN/PI3K/Akt pathway.
    Oncol Rep. 2017 Sep 4. doi: 10.3892/or.2017.5938.
    PubMed     Text format     Abstract available


    August 2017
  74. KONG R, Liu W, Guo Y, Feng J, et al
    Inhibition of NOB1 by microRNA-330-5p overexpression represses cell growth of non-small cell lung cancer.
    Oncol Rep. 2017 Aug 28. doi: 10.3892/or.2017.5927.
    PubMed     Text format     Abstract available


  75. FUNAKI S, Shintani Y, Kawamura T, Kanzaki R, et al
    Chemotherapy enhances programmed cell death 1/ligand 1 expression via TGF-beta induced epithelial mesenchymal transition in non-small cell lung cancer.
    Oncol Rep. 2017 Aug 9. doi: 10.3892/or.2017.5894.
    PubMed     Text format     Abstract available


  76. TANG T, Huan L, Zhang S, Zhou H, et al
    MicroRNA-212 functions as a tumor-suppressor in human non-small cell lung cancer by targeting SOX4.
    Oncol Rep. 2017 Aug 7. doi: 10.3892/or.2017.5885.
    PubMed     Text format     Abstract available


    July 2017
  77. WANG D, Cao Q, Qu M, Xiao Z, et al
    MicroRNA-616 promotes the growth and metastasis of non-small cell lung cancer by targeting SOX7.
    Oncol Rep. 2017 Jul 28. doi: 10.3892/or.2017.5854.
    PubMed     Text format     Abstract available


  78. ZHOU F, Nie L, Feng D, Guo S, et al
    MicroRNA-379 acts as a tumor suppressor in non-small cell lung cancer by targeting the IGF1R-mediated AKT and ERK pathways.
    Oncol Rep. 2017 Jul 18. doi: 10.3892/or.2017.5835.
    PubMed     Text format     Abstract available


  79. WANG Y, Zhao M, Liu J, Sun Z, et al
    miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3beta signaling pathway.
    Oncol Rep. 2017 Jul 12. doi: 10.3892/or.2017.5808.
    PubMed     Text format     Abstract available


  80. HONG CF, Chen WY, Wu CW
    Upregulation of Wnt signaling under hypoxia promotes lung cancer progression.
    Oncol Rep. 2017 Jul 12. doi: 10.3892/or.2017.5807.
    PubMed     Text format     Abstract available


    June 2017
  81. KIM GT, Kim SY, Kim YM
    Torilis japonica extract fraction compound, EGFR-targeted inhibition of cancer abnormal metastasis in A549 lung cancer cells.
    Oncol Rep. 2017 Jun 30. doi: 10.3892/or.2017.5771.
    PubMed     Text format     Abstract available


  82. ZHANG Z, Rui W, Wang ZC, Liu DX, et al
    Anti-proliferation and anti-metastasis effect of barbaloin in non-small cell lung cancer via inactivating p38MAPK/Cdc25B/Hsp27 pathway.
    Oncol Rep. 2017 Jun 27. doi: 10.3892/or.2017.5760.
    PubMed     Text format     Abstract available


  83. TANG Y, He R, An J, Deng P, et al
    lncRNA XIST interacts with miR-140 to modulate lung cancer growth by targeting iASPP.
    Oncol Rep. 2017 Jun 26. doi: 10.3892/or.2017.5751.
    PubMed     Text format     Abstract available


  84. XU Z, Yan Y, Zeng S, Qian L, et al
    Reducing autophagy and inducing G1 phase arrest by aloperine enhances radio-sensitivity in lung cancer cells.
    Oncol Rep. 2017 Jun 19. doi: 10.3892/or.2017.5732.
    PubMed     Text format     Abstract available


  85. ZENG Y, Zhu J, Qin H, Shen D, et al
    Methylated +322-327 CpG site decreases hOGG1 mRNA expression in non-small cell lung cancer.
    Oncol Rep. 2017 Jun 1. doi: 10.3892/or.2017.5690.
    PubMed     Text format     Abstract available


  86. XU W, Wu B, Fu L, Chen J, et al
    Comparison of three different methods for the detection of circulating tumor cells in mice with lung metastasis.
    Oncol Rep. 2017;37:3219-3226.
    PubMed     Text format     Abstract available


  87. SEIKE M, Kim CH, Zou F, Noro R, et al
    AXL and GAS6 co-expression in lung adenocarcinoma as a prognostic classifier.
    Oncol Rep. 2017;37:3261-3269.
    PubMed     Text format     Abstract available


    May 2017
  88. SCHLUCKEBIER L, Aran V, De Moraes J, Paiva H, et al
    XAF1 expression levels in a non-small cell lung cancer cohort and its potential association with carcinogenesis.
    Oncol Rep. 2017 May 30. doi: 10.3892/or.2017.5680.
    PubMed     Text format     Abstract available


  89. LIU L, Xiao L, Liang X, Chen L, et al
    TRIM28 knockdown increases sensitivity to etoposide by upregulating E2F1 in non-small cell lung cancer.
    Oncol Rep. 2017 May 11. doi: 10.3892/or.2017.5638.
    PubMed     Text format     Abstract available


  90. TANG F, Hu P, Yang Z, Xue C, et al
    SBI0206965, a novel inhibitor of Ulk1, suppresses non-small cell lung cancer cell growth by modulating both autophagy and apoptosis pathways.
    Oncol Rep. 2017 May 10. doi: 10.3892/or.2017.5635.
    PubMed     Text format     Abstract available


  91. LI GJ, Zhao GQ, Yang JP, Zhou YC, et al
    Effect of miR-1244 on cisplatin-treated non-small cell lung cancer via MEF2D expression.
    Oncol Rep. 2017 May 4. doi: 10.3892/or.2017.5624.
    PubMed     Text format     Abstract available


  92. YE Z, Fang B, Pan J, Zhang N, et al
    miR-138 suppresses the proliferation, metastasis and autophagy of non-small cell lung cancer by targeting Sirt1.
    Oncol Rep. 2017 May 3. doi: 10.3892/or.2017.5619.
    PubMed     Text format     Abstract available


  93. YAN J, Ma C, Gao Y
    MicroRNA-30a-5p suppresses epithelial-mesenchymal transition by targeting profilin-2 in high invasive non-small cell lung cancer cell lines.
    Oncol Rep. 2017;37:3146-3154.
    PubMed     Text format     Abstract available


  94. WANG J, Wang Y, Sun D, Ren F, et al
    CUTL1 induces epithelial-mesenchymal transition in non-small cell lung cancer.
    Oncol Rep. 2017;37:3068-3074.
    PubMed     Text format     Abstract available


  95. CHEN G, Yu H, Satherley L, Zabkiewicz C, et al
    The downstream of tyrosine kinase 7 is reduced in lung cancer and is associated with poor survival of patients with lung cancer.
    Oncol Rep. 2017;37:2695-2701.
    PubMed     Text format     Abstract available


  96. CAI Y, Ruan J, Yao X, Zhao L, et al
    MicroRNA-187 modulates epithelial-mesenchymal transition by targeting PTRF in non-small cell lung cancer.
    Oncol Rep. 2017;37:2787-2794.
    PubMed     Text format     Abstract available


  97. SUZAWA K, Yamamoto H, Ohashi K, Hashida S, et al
    Optimal method for quantitative detection of plasma EGFR T790M mutation using droplet digital PCR system.
    Oncol Rep. 2017;37:3100-3106.
    PubMed     Text format     Abstract available


  98. WANG X, Li M, Hu M, Wei P, et al
    BAMBI overexpression together with beta-sitosterol ameliorates NSCLC via inhibiting autophagy and inactivating TGF-beta/Smad2/3 pathway.
    Oncol Rep. 2017;37:3046-3054.
    PubMed     Text format     Abstract available


    April 2017
  99. ZHANG Y, Sui J, Shen X, Li C, et al
    Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Oncol Rep. 2017 Apr 28. doi: 10.3892/or.2017.5612.
    PubMed     Text format     Abstract available


  100. WANG H, Zhan Y, Jin J, Zhang C, et al
    MicroRNA-15b promotes proliferation and invasion of nonsmall cell lung carcinoma cells by directly targeting TIMP2.
    Oncol Rep. 2017 Apr 26. doi: 10.3892/or.2017.5604.
    PubMed     Text format     Abstract available


  101. YOO HS, Kim JM, Jo E, Cho CK, et al
    Modified Panax ginseng extract regulates autophagy by AMPK signaling in A549 human lung cancer cells.
    Oncol Rep. 2017 Apr 20. doi: 10.3892/or.2017.5590.
    PubMed     Text format     Abstract available


  102. WANG W, Zhang L, Liu L, Zheng Y, et al
    Chemosensitizing effect of shRNA-mediated ERCC1 silencing on a Xuanwei lung adenocarcinoma cell line and its clinical significance.
    Oncol Rep. 2017;37:1989-1997.
    PubMed     Text format     Abstract available


  103. SHEN F, Long D, Yu T, Chen X, et al
    Vinblastine differs from Taxol as it inhibits the malignant phenotypes of NSCLC cells by increasing the phosphorylation of Op18/stathmin.
    Oncol Rep. 2017;37:2481-2489.
    PubMed     Text format     Abstract available


  104. ZHANG R, Gu J, Chen J, Ni J, et al
    High expression of PINK1 promotes proliferation and chemoresistance of NSCLC.
    Oncol Rep. 2017;37:2137-2146.
    PubMed     Text format     Abstract available


  105. CHENG R, Lu C, Zhang G, Zhang G, et al
    Overexpression of miR-203 increases the sensitivity of NSCLC A549/H460 cell lines to cisplatin by targeting Dickkopf-1.
    Oncol Rep. 2017;37:2129-2136.
    PubMed     Text format     Abstract available


    March 2017
  106. ZHANG L, Xiao X, An H, Wang J, et al
    Inhibition of CCR7 promotes NF-kappaB-dependent apoptosis and suppresses epithelial-mesenchymal transition in non-small cell lung cancer.
    Oncol Rep. 2017 Mar 23. doi: 10.3892/or.2017.5524.
    PubMed     Text format     Abstract available


  107. XIANG GL, Zhu XH, Lin CZ, Wang LJ, et al
    125I seed irradiation induces apoptosis and inhibits angiogenesis by decreasing HIF-1alpha and VEGF expression in lung carcinoma xenografts.
    Oncol Rep. 2017 Mar 23. doi: 10.3892/or.2017.5521.
    PubMed     Text format     Abstract available


  108. YANG N, Liang Y, Yang P, Ji F, et al
    Propofol suppresses LPS-induced nuclear accumulation of HIF-1alpha and tumor aggressiveness in non-small cell lung cancer.
    Oncol Rep. 2017 Mar 17. doi: 10.3892/or.2017.5514.
    PubMed     Text format     Abstract available


  109. YANG JS, Lin CA, Lu CC, Wen YF, et al
    Carboxamide analog ITR-284 evokes apoptosis and inhibits migration ability in human lung adenocarcinoma A549 cells.
    Oncol Rep. 2017;37:1786-1792.
    PubMed     Text format     Abstract available


  110. TIETJE A, Yang X, Yu X, Wei Y, et al
    MICA/IL-12: A novel bifunctional protein for killer cell activation.
    Oncol Rep. 2017;37:1889-1895.
    PubMed     Text format     Abstract available


    February 2017
  111. KAKE S, Usui T, Ohama T, Yamawaki H, et al
    Death-associated protein kinase 3 controls the tumor progression of A549 cells through ERK MAPK/c-Myc signaling.
    Oncol Rep. 2017;37:1100-1106.
    PubMed     Text format     Abstract available


  112. CHEN T, Gong W, Tian H, Wang H, et al
    Fibroblast growth factor 18 promotes proliferation and migration of H460 cells via the ERK and p38 signaling pathways.
    Oncol Rep. 2017;37:1235-1242.
    PubMed     Text format     Abstract available


  113. KIM MH, Jeong YJ, Cho HJ, Hoe HS, et al
    Delphinidin inhibits angiogenesis through the suppression of HIF-1alpha and VEGF expression in A549 lung cancer cells.
    Oncol Rep. 2017;37:777-784.
    PubMed     Text format     Abstract available


  114. ZHANG B, Zhang Y, Yu D
    Lung cancer gene therapy: Transferrin and hyaluronic acid dual ligand-decorated novel lipid carriers for targeted gene delivery.
    Oncol Rep. 2017;37:937-944.
    PubMed     Text format     Abstract available


  115. LIN D, Kuang G, Wan J, Zhang X, et al
    Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of beta-catenin expression.
    Oncol Rep. 2017;37:895-902.
    PubMed     Text format     Abstract available


    December 2016
  116. FUJIYOSHI K, Yamamoto G, Takahashi A, Arai Y, et al
    High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases.
    Oncol Rep. 2016 Dec 15. doi: 10.3892/or.2016.5323.
    PubMed     Text format     Abstract available


  117. WEN R, Xiao Y, Zhang Y, Yang M, et al
    Identification of a novel transcript isoform of the TTLL12 gene in human cancers.
    Oncol Rep. 2016;36:3172-3180.
    PubMed     Text format     Abstract available


  118. LU X, Guo H, Chen X, Xiao J, et al
    Effect of RhoC on the epithelial-mesenchymal transition process induced by TGF-beta1 in lung adenocarcinoma cells.
    Oncol Rep. 2016;36:3105-3112.
    PubMed     Text format     Abstract available


    October 2016
  119. CHEN X, Li Q, Kan XX, Wang YJ, et al
    Extract of Caulis Spatholobi, a novel blocker targeting tumor cellinduced platelet aggregation, inhibits breast cancer metastasis.
    Oncol Rep. 2016 Oct 19. doi: 10.3892/or.2016.5184.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: